Skip to content

Clinical value of nanocarbon missing sentinel lymph node in gynecological malignant tumor

Clinical value of nanocarbon missing sentinel lymph node in gynecological malignant tumor

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027442
Enrollment
Unknown
Registered
2019-11-13
Start date
2019-11-13
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer, endometrial cancer

Interventions

Gold Standard:Pathological diagnosis
Index test:Tracing&#32
lymph&#32
with&#32
nanocarbon

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 72 Years

Inclusion criteria

Inclusion criteria: 1) all patients underwent gynecological examination and MRI/CT/PET-CT examination; 2) signed the informed consent form for this study; 3) pathologically confirmed as invasive cervical cancer or endometiral cancer 4) laparoscopic minimally invasive surgery

Exclusion criteria

Exclusion criteria: 1) combine malignant tumors other than cervical cancer and endometrial cancer; 2) pathology confirmed distant metastasis; 3) concomitant surgery contraindications; 4) combined with cognitive dysfunction.

Design outcomes

Primary

MeasureTime frame
Black stained lymph node;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactZhongfu Yuan

The First Affiliated Hospital of Zhengzhou University

yzf263@163.com+86 13673665236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026